Long-term Effects Secondary to Cancer Therapy in Children, Pulmonary Complications
Conditions
Keywords
long-term effects secondary to cancer therapy in children, pulmonary complications
Brief summary
RATIONALE: Assessing the long-term effects of bone marrow transplant on lung function in patients may improve the ability to plan treatment. PURPOSE: This clinical trial studies lung function in pediatric patients who have undergone bone marrow transplant.
Detailed description
OBJECTIVES: * Determine the delayed effects of bone marrow transplantation preparative regimens on pulmonary function in children surviving at least 5 years after transplantation for hematologic malignancy. * Determine the relationship between pulmonary function and growth rates in these patients. * Determine the effect of growth hormone treatment on pulmonary function in these patients. * Determine the relationship between pulmonary function and age at time of transplantation in these patients. * Determine the incidence and severity of restrictive pulmonary disease, and whether these factors vary with increasing time after transplantation in these patients. OUTLINE: Patients undergo respiratory history, signs and symptoms assessment, pulmonary function tests (PFT) including spirometry, lung volumes, and diffusion, oxygen saturation by pulse oximetry, and height measurement. Patients are assessed at 5-10 years, 10-15 years, and over 15 years after bone marrow transplantation. Patients with abnormal PFTs are assessed at more frequent intervals as clinically indicated. PROJECTED ACCRUAL: Approximately 280 patients will be accrued for this study.
Interventions
Sponsors
Eligibility
Inclusion criteria
DISEASE CHARACTERISTICS: * Patients who have undergone bone marrow transplantation for hematologic malignancy at least 5 years ago * Disease-free survivors at least 6 years of age AND * Under 18 years of age at time of transplantation * Received prior allogeneic, unrelated donor, syngeneic, or autologous bone marrow transplantation * Able to perform pulmonary function tests PATIENT CHARACTERISTICS: Age: * See Disease Characteristics Performance status: * Not specified Life expectancy: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified PRIOR CONCURRENT THERAPY: Biologic therapy: * See Disease Characteristics Chemotherapy: * Not specified Endocrine therapy: * Not specified Radiotherapy: * Not specified Surgery: * Not specified Other: * Any prior preparative regimen allowed
Countries
United States